Literature DB >> 27854417

Meningitis and encephalitis in Poland in 2014

Iwona Paradowska-Stankiewicz1, Anna Piotrowska2.   

Abstract

AIM OF THE STUDY: The aim of this study was to assess the epidemiology of meningitis and/or encephalitis in Poland in 2014.
INTRODUCTION: In the last three years in Poland, about 3000 cases of meningitis and/or encephalitis of viral or bacterial etiology were recorded annually.
MATERIALS AND METHODS: Assessment of the epidemiological situation of meningitis and/or encephalitis in Poland in 2014, was based on the results of the analysis of epidemiological reports sent to the NIZP-PZH by the Regional Sanitary-Epidemiological Stations published in the annual bulletin “Infectious diseases and poisonings in Poland in 2014” and “Preventive immunizations in Poland in 2014”.
RESULTS: In 2014 in Poland 3488 cases of bacterial meningitis and/or encephalitis were recorded. Almost 61.3% of these were viral infections. SUMMARY AND
CONCLUSIONS: In 2014, in comparison to 2013, a 1.1% increase in the number of cases of meningitis and/or encephalitis was observed and 91% with viral etiology.

Entities:  

Mesh:

Year:  2016        PMID: 27854417

Source DB:  PubMed          Journal:  Przegl Epidemiol        ISSN: 0033-2100


  2 in total

Review 1.  Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list.

Authors:  Thien Phu Do; Angelique Remmers; Henrik Winther Schytz; Christoph Schankin; Sarah E Nelson; Mark Obermann; Jakob Møller Hansen; Alexandra J Sinclair; Andreas R Gantenbein; Guus G Schoonman
Journal:  Neurology       Date:  2018-12-26       Impact factor: 11.800

2.  Chronic alcohol abuse affects the clinical course and outcome of community-acquired bacterial meningitis.

Authors:  Marcin Paciorek; Agnieszka Bednarska; Dominika Krogulec; Michał Makowiecki; Justyna D Kowalska; Dominik Bursa; Anna Świderska; Joanna Puła; Joanna Raczyńska; Agata Skrzat-Klapaczyńska; Magdalena Zielenkiewicz; Marek Radkowski; Tomasz Laskus; Andrzej Horban
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-08-07       Impact factor: 3.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.